Taj Ando Pharmaceuticals represents a partnership between Taj Pharma Group, one of India’s leading research based pharmaceutical companies and Ando Pharma (Pty) Ltd, a South African based pharmaceutical company.
This partnership aims to make branded and generic products more affordable and accessible to its customers through its supply of both high-end pharmaceutical products and non-prescription products. Taj Ando is committed to supplying only the very best products available and ensures this is achieved through its cutting edge research and development.
Ando Pharma (Pty) Ltd is a level 1 Black Economic Empowered (BEE) company, based in Cape Town, South Africa. Ando Pharma provides affordable branded and generic products to the healthcare market. We are in the process of registering multiple products with the Medicines Control Council (MCC) of South Africa, which will benefit both healthcare providers and patients.
In light of the current economic situation, Ando Pharma has recognised the need for cost effective branded and generic products, without negating the quality of our products. Ando Pharma has searched globally for a reputable pharmaceutical manufacturer who was capable of adhering to WHO-GMP, FDA, TGA and UKMHRA standards in manufacturing. With all these accreditations and certifications in place, the natural choice was Taj Pharma India. Through our partnership, our products are manufactured in state of the art manufacturing plants, adhering to strict quality control measures, therefore ensuring our products are of high quality.
Taj Pharma is one of the leading generic and branded pharmaceutical manufacturing companies. It holds top positions in different established markets worldwide and is building a strong presence in many emerging generics markets. Taj have eight manufacturing sites worldwide to support its market standing, having FDA accreditation along with WHO-GMP certifications as minimum standards to operate its manufacturing sites, holding a strong regulatory position and major certifications for most markets. An important component of our partnership is Taj Pharma’s in-house manufacturing and supply of over 200 Active Pharmaceutical Ingredients (API) to pharmaceutical companies worldwide.
Today, Taj Ando market’s more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe. The products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.